The scope of the delegated regulation is to eliminate the obligation to include expiry date on the immediate packaging of unauthorised medicinal products which are used in clinical trials under specific circumstances (e.g. on syringes). This will prevent additional safety and quality risks associated with the relabelling procedure and the need for higher frequency of re-supply potentially leading to delays in trials.